Psychiatric and behavioral disorders in patients undergoing opioid agonist maintenance therapy

The aim of this study was to analyze anxiety, depression, aggression, cognitive impairments, and quality of life in patients receiving methadone maintenance therapy. The study was conducted in 2024 at one of the methadone maintenance therapy sites of the Municipal Enterprise «Dnipropetrovsk multidisciplinary clinical hospital for the provision of psychiatric care» Dnipropetrovsk Regional Council». A total of 150 patients aged 26 to 64 years par­ticipated in the study, including 117 (78.0%) men and 33 (22.0%) women. The participants were divided into the main group (101 individuals) and the comparison group (49 individuals). The study employed clinical-anamnestic, clinical-psycho­pathological, and psychodiagnostic methods, including the Symptom Checklist-90-Revised (SCL-90-R), the Hamilton An­xiety Rating Scale (HAM-A), the Hamilton Depression Rating Scale (HAM-D), the Buss-Durkee Hostility Inventory, the Montreal Cognitive Assessment (MoCA), and the World Health Organization Quality of Life Brief Questionnaire (WHOQOL-BREF). The results indicated that the median levels of depression 13,0 [7,0; 19,0] and anxiety 15,0 [8,0; 22,0] in the total sample and both groups corresponded to a mild severity. Most patients exhibited mild anxiety (60,7%). Depression assessment revealed that the majority of patients either had no depression (28,7%) or presented with mild symptoms (24,0%). The majority of participants had no cognitive impairment (45,3%) or only mild deficits (54,7%). Patients demonstrated normal levels of aggression 19,0 [16,0; 24,0] but exhibited an increased level of hostility 10,0 [8,0; 12,0]. At baseline, mild anxiety and depressive symptoms predominated among patients receiving methadone therapy. Elevated hostility was observed, whereas overall aggression remained within the normative range. Cognitive impairment was absent or mild. These baseline findings may inform the development of differentiated treatment strategies for this cohort.

Authors

Institutions

Publication Details

Journal
Medicni perspektivi
Published
2025-09-29
DOI
https://doi.org/10.26641/2307-0404.2025.3.340755
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychiatric and behavioral disorders in patients undergoing opioid agonist maintenance therapy

N. Halytska-Pasichnyk
Medicni perspektivi
Opioid Use Disorder Treatment
article

Psychiatric and behavioral disorders in patients undergoing opioid agonist maintenance therapy

N. Halytska-Pasichnyk
article en

Abstract

The aim of this study was to analyze anxiety, depression, aggression, cognitive impairments, and quality of life in patients receiving methadone maintenance therapy. The study was conducted in 2024 at one of the methadone maintenance therapy sites of the Municipal Enterprise «Dnipropetrovsk multidisciplinary clinical hospital for the provision of psychiatric care» Dnipropetrovsk Regional Council». A total of 150 patients aged 26 to 64 years par­ticipated in the study, including 117 (78.0%) men and 33 (22.0%) women. The participants were divided into the main group (101 individuals) and the comparison group (49 individuals). The study employed clinical-anamnestic, clinical-psycho­pathological, and psychodiagnostic methods, including the Symptom Checklist-90-Revised (SCL-90-R), the Hamilton An­xiety Rating Scale (HAM-A), the Hamilton Depression Rating Scale (HAM-D), the Buss-Durkee Hostility Inventory, the Montreal Cognitive Assessment (MoCA), and the World Health Organization Quality of Life Brief Questionnaire (WHOQOL-BREF). The results indicated that the median levels of depression 13,0 [7,0; 19,0] and anxiety 15,0 [8,0; 22,0] in the total sample and both groups corresponded to a mild severity. Most patients exhibited mild anxiety (60,7%). Depression assessment revealed that the majority of patients either had no depression (28,7%) or presented with mild symptoms (24,0%). The majority of participants had no cognitive impairment (45,3%) or only mild deficits (54,7%). Patients demonstrated normal levels of aggression 19,0 [16,0; 24,0] but exhibited an increased level of hostility 10,0 [8,0; 12,0]. At baseline, mild anxiety and depressive symptoms predominated among patients receiving methadone therapy. Elevated hostility was observed, whereas overall aggression remained within the normative range. Cognitive impairment was absent or mild. These baseline findings may inform the development of differentiated treatment strategies for this cohort.

Medicni perspektiviVol. 30(3)
Regional Clinical Hospital named after II Mechnikov (UA)
Openalex Percentile: Top 62%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Psychiatric and behavioral disorders in patients undergoing opioid agonist maintenance therapy — N. Halytska-Pasichnyk · Medicni perspektivi (2025) | TGRS Research Map | TGRS